We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Responsive Gel Promotes Bone Growth on Implants

By HospiMedica International staff writers
Posted on 09 Apr 2014
An innovative gel can be used to coat titanium implant surfaces and bind protein molecules that promote bone formation. More...


Researchers at Uppsala University (Sweden) and Institut Laue-Langevin (Grenoble, France) succeeded in binding bone morphogenetic protein 2 (BMP-2) to hyaluronic acid—an anionic, nonsulfated glycosaminoglycan that is one of the chief components of the extracellular matrix (ECM)—with covalently linked bisphosphonate (BP) ligands. The result was a stable hydrogel that they used to coat titanium implants. They also demonstrated that the layer of BMP-2 was stable in water, but could be released slowly by adding solutions that contain calcium ions.

The gel layers, a few millionths of a millimeter thick, were characterized using neutron reflection at the ILL, a technique that provides a detailed picture of what happens at a surface and to track the amount of protein present. The researchers have also launched in-vivo trials in collaboration with the Swedish Agricultural University (SLU; Uppsala, Sweden) of similar materials for metal implants in rabbits. The ongoing studies will provide a step towards transfer of the results to clinical applications. The study was published early online on March 31, 2014, in Advanced Engineering Materials.

“We envisage that the materials will be used in medicine to modulate the healing process in bone,” said Associate Professor Dmitri Ossipov, PhD, of the Uppsala department of medicinal chemistry. “Neutrons are an ideal tool to understand the interactions of metal surfaces, polysaccharide biopolymers, and proteins thanks to a contrast matching technique that highlights only the protein components at the interface.”

“Neutron scattering techniques are increasingly relevant to optimize bio-materials and to study systems that relate to health,” said Giovanna Fragneto, PhD, of the ILL. “The importance of combining conventional laboratory studies with those at a large scale facility to give a complete picture of a process was proven once more.”

Related Links:

Uppsala University
Institut Laue-Langevin
Swedish Agricultural University



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.